PBS listing of dabigatran in jeopardy

The listing of new oral anticoagulants, such as dabigatran, on the PBS is in jeopardy following the release of  a long-awaited and much anticipated Federal Government-led review of the drugs.

The 155-page report by Professor Lloyd Sansom found that the cost-effectiveness and safety of the medications were still in doubt following fresh data on how dabigatran works in real life settings, compared with clinical trial evidence.

The findings have led the